factually
Index/Topics/Ivermectin and Cancer Treatment 2026

Ivermectin and Cancer Treatment 2026

The use of ivermectin in combination with immune-checkpoint drugs for cancer treatment, specifically metastatic triple-negative breast cancer, with a Phase I/II study expected to report by 2026.

Fact-Checks

1 result
Jan 30, 2026
Most Viewed

What ongoing clinical trials are testing ivermectin with immunotherapy in cancer and when will results be reported?

Only a small, early-stage body of clinical research is testing together with immune‑checkpoint drugs in cancer: the clearest, actively reported program is a Phase I/II study combining oral ivermectin ...